EdgeMarket › Instruments › NMTC

NMTC — NEUROONE MEDICAL TECHNOLOGIES Corp

Name: NMTC — NEUROONE MEDICAL TECHNOLOGIES Corp market data and filings
Creator: EdgeMarket

US Healthcare Medical devices equity mkt cap 17.7M

2.03 -5.58% today

USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown

52w low 1.52 · high 6.36

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-05-26.

Performance

1 day-5.58%

1 week+4.64%

1 month+9.73%

3 months-47.95%

6 months-50.25%

Year to date-60.31%

1 year-54.97%

3 years-66.50%

5 years-92.36%

Technicals

RSI 1462.2

vs 50-day avg-15.85%

vs 200-day avg-48.60%

Volatility 1y77.6%

Max drawdown 1y-76.10%

Avg volume 30d59.4K

Daily bars held1,316

History from2021-05-26

Others in Healthcare

LLY +0.9%AKTX +1.6%JNJ +1.1%ONC +1.5%ABBV +1.2%MRK +2.4%UNH +1.4%NVS +1.7%

Measured signals that fired on NMTC

date	signal	measured base rate
2026-03-03	Conviction buy by an officer insider	-1.03% over 21 days · t = -2.24 · n = 1,083 statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

date	insider	what	shares	price	value
2026-06-30	Christianson Mark Market Development Director	Open-market sale	10.0K	3.18	31.8K
2026-04-03	MATHIESEN JEFFREY S Director	Grant or award	41.9K	0.00	0
2026-04-03	Andrle Edward Director	Grant or award	41.9K	0.00	0
2026-04-03	Mills Jason Richard Director	Grant or award	41.9K	0.00	0
2026-04-03	BUCKMAN PAUL Director	Grant or award	41.9K	0.00	0
2026-03-31	Rosa David A CEO and President	Shares withheld for tax	2.5K	0.78	1.9K
2026-03-31	Mertens Steve Chief Technology Officer	Shares withheld for tax	906	0.78	704
2026-03-31	Christianson Mark Business Development Director	Shares withheld for tax	253	0.78	197
2026-03-30	Christianson Mark Business Development Director	Open-market sale	15.4K	0.74	11.4K
2026-03-13	Christianson Mark Business Development Director	Open-market sale	100	0.80	80

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

manager	value	shares
Bleichroeder LP	3.1M	4.0M
BARD ASSOCIATES INC	1.4M	1.8M
PERKINS CAPITAL MANAGEMENT INC	1.1M	1.5M
VANGUARD CAPITAL MANAGEMENT LLC	1.1M	1.4M
RENAISSANCE TECHNOLOGIES LLC	509.0K	655.4K
GEODE CAPITAL MANAGEMENT, LLC	478.1K	615.6K
Sio Capital Management, LLC	385.6K	496.6K
VANGUARD FIDUCIARY TRUST CO	226.9K	292.1K
ESSEX INVESTMENT MANAGEMENT CO LLC	203.4K	262.0K
NORTHERN TRUST CORP	87.1K	112.1K

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Short selling

Avg short volume, 90d44.3% of tape

Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Recent headlines

NeuroOne Medical Technologies GAAP EPS of -$0.28 misses by $0.06, revenue of $2M misses by $0.55M · 2026-08-13
Neuroone Medical Technologies Corp (NMTC) filed form 8-K · 2026-08-13 · SEC EDGAR

Ask the AI about NMTC

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open NMTC in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Create a free account Open the terminal first

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →